Association of shared decision-making cessation model and adult smoking cessation rate: A prospective cohort study.

IF 2.2 4区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Tobacco Induced Diseases Pub Date : 2025-01-31 eCollection Date: 2025-01-01 DOI:10.18332/tid/200023

Kuan-Lun Chen, Yun-Chen Hsu, Yi-Hsuan Li, Fei-Ran Guo, Jaw-Shiun Tsai, Shao-Yi Cheng, Hsien-Liang Huang

{"title":"Association of shared decision-making cessation model and adult smoking cessation rate: A prospective cohort study.","authors":"Kuan-Lun Chen, Yun-Chen Hsu, Yi-Hsuan Li, Fei-Ran Guo, Jaw-Shiun Tsai, Shao-Yi Cheng, Hsien-Liang Huang","doi":"10.18332/tid/200023","DOIUrl":null,"url":null,"abstract":"Introduction: It remains unclear whether shared decision-making (SDM) can help smoking cessation. This study aims to determine whether the SDM model increases the 24-week point abstinence rate and medication adherence rate for adult smokers.Methods: This prospective cohort study, conducted between January 2019 and June 2021, enrolled 1268 adult smokers at the outpatient cessation clinic of a national medical center. SDM-integrated counseling was provided to those opting for the SDM cessation model, involving cessation educators and decision aids. Patients who declined the model received cessation medication. The self-reported 7-day point prevalence abstinence rate at week 24, medication adherence rate, and the proportion of participants agreeing to receive pharmacotherapy were measured.Results: Out of the 1268 participants, 1187 (93.6%) were included in the primary analysis. Of these, 610 (48%) opted for the SDM model. Participants in the SDM group used cessation medication more frequently (83.4% vs 71.9%, p<0.001) and exhibited higher medication adherence (39.1% vs 28.6%, p=0.04). Logistic regression analysis revealed that the SDM group did not demonstrate a significantly higher 7-day point abstinence rate at week 24 (OR=0.89; 95% CI: 0.68-1.15; p=0.37).Conclusions: The SDM cessation model was positively associated with medication adherence and the proportion of participants using pharmacotherapies. However, the association of SDM with the 7-day point prevalence of abstinence at week 24 was not statistically significant. Longer follow-up studies are needed to understand the association of the SDM intervention with absolute abstinence.","PeriodicalId":23202,"journal":{"name":"Tobacco Induced Diseases","volume":"23 ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783649/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco Induced Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18332/tid/200023","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: It remains unclear whether shared decision-making (SDM) can help smoking cessation. This study aims to determine whether the SDM model increases the 24-week point abstinence rate and medication adherence rate for adult smokers.

Methods: This prospective cohort study, conducted between January 2019 and June 2021, enrolled 1268 adult smokers at the outpatient cessation clinic of a national medical center. SDM-integrated counseling was provided to those opting for the SDM cessation model, involving cessation educators and decision aids. Patients who declined the model received cessation medication. The self-reported 7-day point prevalence abstinence rate at week 24, medication adherence rate, and the proportion of participants agreeing to receive pharmacotherapy were measured.

Results: Out of the 1268 participants, 1187 (93.6%) were included in the primary analysis. Of these, 610 (48%) opted for the SDM model. Participants in the SDM group used cessation medication more frequently (83.4% vs 71.9%, p<0.001) and exhibited higher medication adherence (39.1% vs 28.6%, p=0.04). Logistic regression analysis revealed that the SDM group did not demonstrate a significantly higher 7-day point abstinence rate at week 24 (OR=0.89; 95% CI: 0.68-1.15; p=0.37).

Conclusions: The SDM cessation model was positively associated with medication adherence and the proportion of participants using pharmacotherapies. However, the association of SDM with the 7-day point prevalence of abstinence at week 24 was not statistically significant. Longer follow-up studies are needed to understand the association of the SDM intervention with absolute abstinence.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Tobacco Induced Diseases SUBSTANCE ABUSE-PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

CiteScore

5.30

自引率

5.40%

发文量

审稿时长

12 weeks

期刊介绍： Tobacco Induced Diseases encompasses all aspects of research related to the prevention and control of tobacco use at a global level. Preventing diseases attributable to tobacco is only one aspect of the journal, whose overall scope is to provide a forum for the publication of research articles that can contribute to reducing the burden of tobacco induced diseases globally. To address this epidemic we believe that there must be an avenue for the publication of research/policy activities on tobacco control initiatives that may be very important at a regional and national level. This approach provides a very important "hands on" service to the tobacco control community at a global scale - as common problems have common solutions. Hence, we see ourselves as "connectors" within this global community. The journal hence encourages the submission of articles from all medical, biological and psychosocial disciplines, ranging from medical and dental clinicians, through health professionals to basic biomedical and clinical scientists.